Key result
Treating hypertension and dyslipidemia simultaneously with a fixed combination therapy is suggested to increase patient adherence and compliance.
Answers are grounded in this paper and cite their sources.
Fixed-dose combination therapy for coexisting hypertension and dyslipidemia is suggested to reduce pill burden and improve patient adherence.
Hypertension and dyslipidemias represent important risk factors for the occurrence of cardiovascular diseases which have a high mortality rate. Although we know how to treat both, the success rate remains low. More than half of patients need at least two antihypertensive agents to achieve target blood pressure. Also, dyslipidemia frequently coexists and thus the burden of life-long pill taking is high and the adherence is low. We suggest treating both conditions simultaneously in a fixed combination. This would increase patients' adherence and compliance to therapy and therefore provide a more successful management of both conditions.
No takes yet. Share an insight, caveat, or question.
Accetto et al. (2016) conducted a review in Hypertension and dyslipidemia. Fixed combination therapy was evaluated. Treating hypertension and dyslipidemia simultaneously with a fixed combination therapy is suggested to increase patient adherence and compliance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: